Faeth Therapeutics, Inc. (FTH) — Defensive Interval Ratio
Faeth Therapeutics, Inc. (FTH) has a Defensive Interval Ratio of 1298 days as of March 2026. Defensive assets of $50.47 Million (cash $-, short-term investments $50.47 Million, receivables $-) cover 1298 days of daily cash needs of $38.88K/day. See Faeth Therapeutics, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Faeth Therapeutics, Inc. Defensive Interval Ratio (2021–2025)
This chart shows how Faeth Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 1298 days, meaning defensive assets of $50.47 Million can fund 1298 days of operations without new revenue. See how leveraged is Faeth Therapeutics, Inc.'s balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Faeth Therapeutics, Inc. (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Faeth Therapeutics, Inc. from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Faeth Therapeutics, Inc. (FTH) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1075 days | $12.52 Million | $11.65K/day | $- | $12.52 Million | ▼ -1025 days |
| 2024 | 2100 days | $31.34 Million | $14.93K/day | $- | $31.34 Million | ▼ -1312 days |
| 2023 | 3412 days | $52.75 Million | $15.46K/day | $- | $52.75 Million | ▼ -184 days |
| 2022 | 3596 days | $89.32 Million | $24.84K/day | $- | $89.32 Million | ▼ -6890 days |
| 2021 | 10487 days | $140.46 Million | $13.39K/day | $- | $140.46 Million | — |